ArticleNeoplasia (New York, N.Y.)2014

SC-2001 overcomes STAT3-mediated sorafenib resistance through RFX-1/SHP-1 activation in hepatocellular carcinoma.

Jung-Chen Su et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.